{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:15:33Z","timestamp":1768893333222,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12918-019-0700-4","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T10:06:02Z","timestamp":1553076362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["PMAMCA: prediction of microRNA-disease association utilizing a matrix completion approach"],"prefix":"10.1186","volume":"13","author":[{"given":"Jihwan","family":"Ha","sequence":"first","affiliation":[]},{"given":"Chihyun","family":"Park","sequence":"additional","affiliation":[]},{"given":"Sanghyun","family":"Park","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"700_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431:350\u20135.","journal-title":"Nature"},{"key":"700_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"700_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature02873","volume":"431","author":"G Meister","year":"2004","unstructured":"Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431:343\u20139.","journal-title":"Nature"},{"key":"700_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","volume":"107","author":"V Ambros","year":"2001","unstructured":"Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107:823\u20136.","journal-title":"Cell"},{"key":"700_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2105-14-S12-S1","volume":"14","author":"M Alshalalfa","year":"2013","unstructured":"Alshalalfa M, Alhajj R. Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures. BMC Bioinforma. 2013;14:S1.","journal-title":"BMC Bioinforma"},{"key":"700_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell"},{"key":"700_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.tig.2004.09.010","volume":"20","author":"P Xu","year":"2004","unstructured":"Xu P, Guo M, Hay BA. microRNAs and the regulation of cell death. Trends Genet. 2004;20:617\u201324.","journal-title":"Trends Genet"},{"key":"700_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/nar\/gki200","volume":"33","author":"AM Cheng","year":"2005","unstructured":"Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33:1290\u20137.","journal-title":"Nucleic Acids Res"},{"key":"700_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1126\/science.1121566","volume":"310","author":"X Karp","year":"2005","unstructured":"Karp X, Ambros V. Encountering microRNAs in cell fate signaling. Science. 2005;310:1288\u20139.","journal-title":"Science"},{"key":"700_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.gde.2005.08.005","volume":"15","author":"EA Miska","year":"2005","unstructured":"Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563\u20138.","journal-title":"Curr Opin Genet Dev"},{"key":"700_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1101\/gad.1974211","volume":"25","author":"KJ Png","year":"2011","unstructured":"Png KJ, et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev. 2011;25:226\u201331.","journal-title":"Genes Dev"},{"key":"700_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451:147\u201352.","journal-title":"Nature"},{"key":"700_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","volume":"137","author":"S Valastyan","year":"2009","unstructured":"Valastyan S, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009;137:1032\u201346.","journal-title":"Cell"},{"key":"700_CR14","doi-asserted-by":"publisher","first-page":"e46173","DOI":"10.1371\/journal.pone.0046173","volume":"7","author":"R Wang","year":"2012","unstructured":"Wang R, et al. MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1. PLoS One. 2012;7:e46173.","journal-title":"PLoS One"},{"key":"700_CR15","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1016\/j.febslet.2014.09.045","volume":"588","author":"R Wang","year":"2014","unstructured":"Wang R, et al. MiR-185 is involved in human breast carcinogenesis by targeting Vegfa. FEBS Lett. 2014;588:4438\u201347.","journal-title":"FEBS Lett"},{"key":"700_CR16","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99:15524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"700_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2156-6-45","volume":"6","author":"C Perez-Iratxeta","year":"2005","unstructured":"Perez-Iratxeta C, Wjst M, Bork P, Andrade MA. G2D: a tool for mining genes associated with disease. BMC Genet. 2005;6:45.","journal-title":"BMC Genet"},{"key":"700_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ng895","volume":"31","author":"C Perez-Iratxeta","year":"2002","unstructured":"Perez-Iratxeta C, Bork P, Andrade MA. Association of genes to genetically inherited diseases using data mining. Nat Gene. 2002;31:316\u20139.","journal-title":"Nat Gene"},{"key":"700_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nbt1203","volume":"24","author":"S Aerts","year":"2006","unstructured":"Aerts S, et al. Gene prioritization through genomic data fusion. Nat Biotechnol. 2006;24:537\u201344.","journal-title":"Nat Biotechnol"},{"key":"700_CR20","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1752-0509-4-S1-S2","volume":"4","author":"Q Jiang","year":"2010","unstructured":"Jiang Q, et al. Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Syst Biol. 2010;4:S2.","journal-title":"BMC Syst Biol"},{"key":"700_CR21","doi-asserted-by":"crossref","unstructured":"Jiang Q, Wang G, Wang Y. An approach for prioritizing disease-related micrornas based on genomic data integration. In Biomedical Engineering and Informatics (BMEI), 2010 3rd International Conference On. Volume 6. IEEE;","DOI":"10.1109\/BMEI.2010.5639313"},{"key":"700_CR22","unstructured":"Zeng X, Zhang X, Zou Q. Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks. Briefings in bioinformatic. bbv033. 2015;17:193\u2013203."},{"key":"700_CR23","first-page":"810514","volume":"2015","author":"Q Zou","year":"2015","unstructured":"Zou Q, et al. Prediction of microRNA-disease associations based on social network analysis methods. Biomed. Res. 2015;2015:810514.","journal-title":"Biomed. Res"},{"key":"700_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/bioinformatics\/btx622","volume":"34","author":"W Tang","year":"2018","unstructured":"Tang W, Wan S, Yang Z, Teschendorff AE, Zou Q. Tumor origin detection with tissue-specific miRNA and DNA methylation markers. Bioinformatics. 2018;34:398\u2013406.","journal-title":"Bioinformatics"},{"key":"700_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/bib\/bbv033","volume":"17","author":"X Zeng","year":"2016","unstructured":"Zeng X, Zhang X, Zou Q. Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks. Brief Bioinform. 2016;17:193\u2013203.","journal-title":"Brief Bioinform"},{"issue":"s1","key":"700_CR26","first-page":"S1763","volume":"26","author":"J Ha","year":"2015","unstructured":"Ha J, Kim H, Yoon Y, Park S. A method of extracting disease-related microRNAs through the propagation algorithm using the environmental factor based global miRNA network, Bio-Med. Mater Eng. 2015;26(s1):S1763\u201372.","journal-title":"Mater Eng"},{"key":"700_CR27","doi-asserted-by":"publisher","first-page":"21106","DOI":"10.1038\/srep21106","volume":"6","author":"X Chen","year":"2016","unstructured":"Chen X, Yan CC, Zhang X, You ZH, Deng L, Liu Y, Zhang Y, Dai Q. WBSMDA: Within and between score for MiRNA-disease association prediction. Sci Rep. 2016;6:21106.","journal-title":"Sci Rep"},{"key":"700_CR28","doi-asserted-by":"crossref","unstructured":"Chen X, Liu M-X, Yan G-Y. RWRMDA: predicting novel human microRNA\u2013disease associations. Mol BioSyst. 2012;8:2792\u20138.","DOI":"10.1039\/c2mb25180a"},{"key":"700_CR29","doi-asserted-by":"crossref","unstructured":"Chen X, Yan G-Y. Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep. 2014;4:5501.","DOI":"10.1038\/srep05501"},{"key":"700_CR30","doi-asserted-by":"publisher","first-page":"e70204","DOI":"10.1371\/journal.pone.0070204","volume":"8","author":"P Xuan","year":"2013","unstructured":"Xuan P, et al. Prediction of microRNAs associated with human diseases based on weighted k Most similar neighbors. PLoS One. 2013;8:e70204.","journal-title":"PLoS One"},{"key":"700_CR31","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1093\/nar\/gkm480","volume":"35","author":"Z Yu","year":"2007","unstructured":"Yu Z, et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 2007;35:4535\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl. 1","key":"700_CR32","first-page":"S2","volume":"4","author":"QH Jiang","year":"2010","unstructured":"Jiang QH, Hao YY, Wang GH, Juan LR, Zhang TJ, Teng MX, Liu YL, Wang YD. BMC Syst. Biol. 2010;4(Suppl. 1):S2.","journal-title":"Biol"},{"key":"700_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/sj.ejhg.5201585","volume":"14","author":"MA Driel Van","year":"2006","unstructured":"Van Driel MA, Bruggeman J, Vriend G, et al. A text-mining analysis of the human phenome. Eur J Hum Genet. 2006;14:535\u201342.","journal-title":"Eur J Hum Genet"},{"key":"700_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.01977","volume":"3","author":"T Isobe","year":"2014","unstructured":"Isobe T, Hisamori S, Hogan DJ, Zabala M, Hendrickson DG, Dalerba P, et al. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. Elife. 2014;3:1\u201323.","journal-title":"Elife"},{"key":"700_CR35","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/onc.2013.226","volume":"33","author":"Q Li","year":"2014","unstructured":"Li Q, Yao Y, Eades G, Liu Z, Zhang Y, Zhou Q. Down regulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene. 2014;33:2589\u2013600.","journal-title":"Oncogene"},{"issue":"1 Suppl","key":"700_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y","volume":"75","author":"WD Travis","year":"1995","unstructured":"Travis WD, Travis LB, Devesa SS. Lung cancer [published erratum appears in Cancer 1995;75:2979]. Cancer. 1995;75(1 Suppl):191\u2013202.","journal-title":"Cancer"},{"key":"700_CR37","doi-asserted-by":"publisher","first-page":"15945","DOI":"10.1038\/s41598-017-16112-y","volume":"7","author":"T Kawaguchi","year":"2017","unstructured":"Kawaguchi T, Yan L, Qi Q, et al. Overexpression of suppressive microRNAs, miR-30a and miR200c are associated with improved survival of breast cancer patients. Sci Rep. 2017;7:15945.","journal-title":"Sci Rep"},{"issue":"49","key":"700_CR38","doi-asserted-by":"publisher","first-page":"41514","DOI":"10.1074\/jbc.M112.404871","volume":"287","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, et al. Estrogen receptor \u03b1 signaling regulates breast tumor-initiating cells by Down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem. 2012;287(49):41514\u201322.","journal-title":"J Biol Chem"},{"issue":"12","key":"700_CR39","doi-asserted-by":"publisher","first-page":"e0143993","DOI":"10.1371\/journal.pone.0143993","volume":"10","author":"A Schwickert","year":"2015","unstructured":"Schwickert A, et al. microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements. PLoS One. 2015;10(12):e0143993.","journal-title":"PLoS One"},{"key":"700_CR40","first-page":"10800","volume":"8","author":"P Xiao","year":"2015","unstructured":"Xiao P, Liu WL. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Int J Clin Exp Pathol. 2015;8:10800\u20137.","journal-title":"Int J Clin Exp Pathol"},{"key":"700_CR41","doi-asserted-by":"crossref","unstructured":"Shen WW, et al. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. J Mol Med. 2013;91(8):989-1000.","DOI":"10.1007\/s00109-013-1037-x"},{"key":"700_CR42","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/onc.2016.332","volume":"36","author":"L Shi","year":"2017","unstructured":"Shi L, Wang Y, Zu Z, Zhang H, Zhuang N, Wang B, et al. miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop. Oncogene. 2017;36:1631\u201343.","journal-title":"Oncogene"},{"issue":"6","key":"700_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","volume":"9","author":"Y Saito","year":"2006","unstructured":"Saito Y, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 2006;9(6):435\u201343.","journal-title":"Cancer Cell"},{"key":"700_CR44","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"29","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, et al. Cancer genome landscapes. Science. 2013;29:1546\u201358.","journal-title":"Science"},{"key":"700_CR45","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1073\/pnas.1213968110","volume":"110","author":"CD McFarland","year":"2013","unstructured":"McFarland CD, Korolev KS, Kryukov GV, Sunyaev SR, Mirnya LA. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci U S A. 2013;110:2910\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"700_CR46","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1038\/s41598-017-06659-1","volume":"7","author":"FA Marchi","year":"2017","unstructured":"Marchi FA, et al. Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma. Sci Rep. 2017;7:6707.","journal-title":"Sci Rep"},{"key":"700_CR47","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1097\/JTO.0b013e3182217d81","volume":"6","author":"KL Thu","year":"2011","unstructured":"Thu KL, Chari R, Lockwood WW, Lam S, Lam WL. miR-101 DNA copy loss is a prominent subtype specific event in lung cancer. J Thorac Oncol. 2011;6:1594\u20138.","journal-title":"J Thorac Oncol"},{"key":"700_CR48","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/cgt.2009.88","volume":"17","author":"Y Akao","year":"2010","unstructured":"Akao Y, Nakagawa Y, et al. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010;17:398\u2013408.","journal-title":"Cancer Gene Ther"},{"key":"700_CR49","doi-asserted-by":"publisher","first-page":"30288","DOI":"10.18632\/oncotarget.16327","volume":"8","author":"K Koshizuka","year":"2017","unstructured":"Koshizuka K, Nohata N, Hanazawa T, et al. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of premiR-150 as antitumor miRNAs. Oncotarget. 2017;8:30288\u2013304.","journal-title":"Oncotarget"},{"key":"700_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamaoncol.2015.3413","volume":"2","author":"S Gao","year":"2016","unstructured":"Gao S, Tibiche C, Zou J, Zaman N, Trifiro M, O\u2019Connor-McCourt M, Wang E. Identification and construction of combinatory Cancer Hallmark-based gene signature sets to predict recurrence and chemotherapy benefit in stage II colorectal Cancer. JAMA Oncol. 2016;2:37\u201345.","journal-title":"JAMA Oncol"},{"key":"700_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2014.04.002","volume":"30","author":"E Wang","year":"2015","unstructured":"Wang E, Zaman N, Mcgee S, et al. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Semin Cancer Biol. 2015;30:4\u201312.","journal-title":"Semin Cancer Biol"},{"key":"700_CR52","first-page":"e1450","volume":"3","author":"C Alderman","year":"2016","unstructured":"Alderman C, Yang Y. The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p. RNA Dis (Houston, Tex.). 2016;3:e1450.","journal-title":"RNA Dis (Houston, Tex.)"},{"key":"700_CR53","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46:D296\u2013302.","journal-title":"Nucleic Acids Res"},{"key":"700_CR54","doi-asserted-by":"publisher","first-page":"D105","DOI":"10.1093\/nar\/gkn851","volume":"37","author":"F Xiao","year":"2009","unstructured":"Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. MiRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37:D105\u201310.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-019-0700-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-019-0700-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-019-0700-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:09:30Z","timestamp":1584576570000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-019-0700-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["700"],"URL":"https:\/\/doi.org\/10.1186\/s12918-019-0700-4","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"16 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"33"}}